Exploring the Genetic and Transcriptomic Landscape of Obsessive-Compulsive Disorder: A Machine Learning-Driven Investigation of lncRNA BDNF-AS

Document Type : Research Paper

Authors

1 Department of Health Psychology, Karaj Branch, Islamic Azad University, Karaj, Iran

2 Department of Psychology, Islamic Azad University, Tonekabon Branch, Tonekabon, Iran

3 Department of Psychology, Karaj Branch, Islamic Azad University, Karaj, Iran.

4 Department of Psychology, Karaj Branch, Islamic Azad University, Karaj, Iran

Abstract

Obsessive-compulsive disorder (OCD) is a multifaceted mental health condition characterized by intrusive thoughts and repetitive behaviors, with its origins remaining poorly understood. While genetic factors are acknowledged to contribute to its development, the specific molecular mechanisms underlying OCD are still largely unexplored. This study employed a machine learning approach to investigate the role of long non-coding RNA (lncRNA) BDNF-AS in relation to the BDNF Val66Met polymorphism and its association with OCD. Our comprehensive analysis of various genomic and transcriptomic datasets revealed a significant upregulation of lncRNA BDNF-AS in OCD patients carrying the BDNF Val66Met variant compared to those who do not possess this genetic variant. Importantly, we observed a dose-dependent relationship between BDNF genotype and BDNF-AS expression, with individuals carrying the Val/Met and Met/Met genotypes exhibiting notably higher levels of expression. These findings suggest a potential connection between the dysregulation of BDNF-AS and the BDNF Val66Met polymorphism in the pathogenesis of OCD. Given that BDNF-AS is known to regulate BDNF expression and signaling—both of which are crucial for neuronal function and synaptic plasticity—disruptions in these pathways may play a significant role in the development of OCD. Identifying this lncRNA-mediated mechanism not only enhances our understanding of OCD's molecular basis but also holds promise for the development of novel biomarkers and targeted therapeutic strategies, paving the way for personalized treatment approaches.

Keywords

Main Subjects

References

Baira, E., Greshock, J., Coukos, G., & Zhang, L. (2008). Ultraconserved elements: genomics, function and disease. RNA biology, 5(3), 132-134.
Blanco-Vieira, T., Radua, J., Marcelino, L., Bloch, M., Mataix-Cols, D., & do Rosário, M. C. (2023). The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysis. Translational psychiatry, 13(1), 230.  DOI: 10.1038/s41398-023-02433-2
Bozorgmehr, A., Ghadirivasfi, M., & Shahsavand Ananloo, E. (2017). Obsessive–compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology. Journal of neurogenetics, 31(3), 153-160. DOI: 10.1080/01677063.2017.1336236
Brander, G., Perez-Vigil, A., Larsson, H., & Mataix-Cols, D. (2016). Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation. Neuroscience & Biobehavioral Reviews, 65, 36-62. DOI: 10.1016/j.neubiorev.2016.03.011
Cervin, M. (2023). Obsessive-compulsive disorder: diagnosis, clinical features, nosology, and epidemiology. Psychiatric Clinics, 46(1), 1-16. DOI: 10.1016/j.psc.2022.10.006Style
Cipolla, G. A., De Oliveira, J. C., Salviano-Silva, A., Lobo-Alves, S. C., Lemos, D. S., Oliveira, L. C., Jucoski, T. S., Mathias, C., Pedroso, G. A., Zambalde, E. P., & Gradia, D. F. (2018). Long Non-Coding RNAs in Multifactorial Diseases: Another Layer of Complexity. Non-Coding RNA, 4(2), 13. https://doi.org/10.3390/ncrna4020013
Cummins, M., Watson, C., Edwards, R. J., & Mattick, J. S. (2024). The evolution of ultraconserved elements in vertebrates. Molecular biology and evolution, 41(7). https://doi.org/10.1093/molbev/msae146
de Assis, G. G., & Hoffman, J. R. (2022). The BDNF Val66Met Polymorphism is a relevant, but not determinant, risk factor in the etiology of neuropsychiatric disorders–current advances in human studies: a systematic review. Brain Plasticity, 8(2), 133-142. DOI: 10.3233/BPL-210132
González-Castro, T. B., Pool-García, S., Tovilla-Zárate, C. A., Juárez-Rojop, I. E., López-Narváez, M. L., Frésan, A., . . . Nicolini, H. (2019). Association between BDNF Val66Met polymorphism and generalized anxiety disorder and clinical characteristics in a Mexican population: A case–control study. Medicine, 98(11), e14838. DOI: 10.1097/MD.0000000000014838
Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Delgado, P., Heninger, G. R., & Charney, D. S. (1989). The yale-brown obsessive compulsive scale: IlI. Validity. Archives of general psychiatry, 46(11), 1012-1016.
Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Charney, D. S. (1989). The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Archives of general psychiatry, 46(11), 1006-1011.
Gruenblatt, E., Hauser, T. U., & Walitza, S. (2014). Imaging genetics in obsessive-compulsive disorder: linking genetic variations to alterations in neuroimaging. Progress in Neurobiology, 121, 114-124.
Hemmings, S. M. J., Lochner, C., van der Merwe, L., Cath, D. C., Seedat, S., & Stein, D. J. (2013). BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder. Journal of Psychiatric Research, 47(12), 1857-1863.  DOI: 10.1016/j.jpsychires.2013.08.012
Koshimizu, H., Kiyosue, K., Hara, T., Hazama, S., Suzuki, S., Uegaki, K., . . . Tatsu, Y. (2009). Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Molecular brain, 2, 1-19.  DOI: 10.1186/1756-6606-2-27
Liu, T., Li, H., Colton, J. P., Ge, S., & Li, C. (2020). The BDNF Val66Met polymorphism, regular exercise, and cognition: A systematic review. Western Journal of Nursing Research, 42(8), 660–673. https://doi.org/10.1177/0193945920907308
Mahjani, B., Bey, K., Boberg, J., & Burton, C. (2021). Genetics of obsessive-compulsive disorder. Psychological Medicine, 51(13), 2247-2259. DOI: 10.1017/S0033291721001744
Nemeth, K., Bayraktar, R., Ferracin, M., & Calin, G. A. (2024). Non-coding RNAs in disease: from mechanisms to therapeutics. Nature Reviews Genetics, 25(3), 211-232. DOI: 10.1038/s41576-023-00662-1
Nicolini, H., Salin-Pascual, R., Cabrera, B., & Lanzagorta, N. (2017). Influence of culture in obsessive-compulsive disorder and its treatment. Current psychiatry reviews, 13(4), 285-292.  DOI: 10.2174/2211556007666180115105935
Nurk, S., Koren, S., Rhie, A., Rautiainen, M., Bzikadze, A. V., Mikheenko, A., . . . Gershman, A. (2022). The complete sequence of a human genome. Science, 376(6588), 44-53. DOI: 10.1126/science.abj6987
Pathak, P., Mehra, A., Ram, S., Pal, A., & Grover, S. (2022). Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy. Behavioural Brain Research, 430, 113931. DOI: 10.1016/j.bbr.2022.113931
Rajendram, R., Kronenberg, S., Burton, C. L., & Arnold, P. D. (2017). Glutamate genetics in obsessive-compulsive disorder: a review. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 26(3), 205.
Schiele, M. A., Reif, A., Lin, J., Alpers, G. W., Andersson, E., Andersson, G., . . . Eley, T. C. (2021). Therapygenetic effects of 5-HTTLPR on cognitive-behavioral therapy in anxiety disorders: A meta-analysis. European Neuropsychopharmacology, 44, 105-120. DOI: 10.1016/j.euroneuro.2021.01.004
Soltan, M. R., Dessoki, H. H., Abbas, M. M., Mahmoud, L. H., & Dawoud, M. E. (2023). Study of insight in patients with obsessive compulsive disorder and its relation to executive functions and serum brain-derived neurotrophic factor. Middle East Current Psychiatry, 30(1), 75. https://doi.org/10.1186/s43045-023-00348-8
Sulaimani, M. F., & Bagadood, N. H. (2021). Implication of coronavirus pandemic on obsessive-compulsive-disorder symptoms. Reviews on environmental health, 36(1), 1-8. DOI: 10.1515/reveh-2020-0054
Valley, C. C., Cembran, A., Perlmutter, J. D., Lewis, A. K., Labello, N. P., Gao, J., & Sachs, J. N. (2012). The methionine-aromatic motif plays a unique role in stabilizing protein structure. Journal of Biological Chemistry, 287(42), 34979-34991. DOI: 10.1074/jbc.M112.374504
Wang, L., Chen, Y., Wang, M., Zhao, C., & Qiao, D. (2023). Relationship between gene-environment interaction and obsessive-compulsive disorder: A systematic review. Journal of Psychiatric Research, 164, 281-290. https://doi.org/10.1016/j.jpsychires.2023.06.004
Wang, Y., Li, O., Li, N., Sha, Z., Zhao, Z., & Xu, J. (2023). Association between the BDNF Val66Met polymorphism and major depressive disorder: a systematic review and meta-analysis. Frontiers in Psychiatry, 14, 1143833. DOI: 10.3389/fpsyt.2023.1143833
Wang, Y., Zhang, H., Li, Y., Wang, Z., Fan, Q., Yu, S., Xiao, Z. (2015). BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder. Journal of affective disorders, 186, 7-12. DOI: 10.1016/j.jad.2015.07.023
Zai, G., Zai, C. C., Arnold, P. D., Freeman, N., Burroughs, E., Kennedy, J. L., & Richter, M. A. (2015). Meta-analysis and association of brain-derived neurotrophic factor (BDNF) gene with obsessive-compulsive disorder. Psychiatric genetics, 25(2), 95-96. doi: 10.1097/YPG.0000000000000077
Zou, Y., Zhang, Y., Tu, M., Ye, Y., Li, M., Ran, R., & Zou, Z. (2024). Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 110954. DOI: 10.1016/j.pnpbp.2024.110954
 
Microbiology, Metabolites and Biotechnology
Volume 7, Issue 1
June 2024
Pages 38-47

Files

Share

How to cite

Statistics